{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:27:33Z","timestamp":1790749653081,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"publisher","award":["23K24288"],"award-info":[{"award-number":["23K24288"]}],"id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019353","name":"Okayama University of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["507803309"],"award-info":[{"award-number":["507803309"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["424778381"],"award-info":[{"award-number":["424778381"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.semnuclmed.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:00:50Z","timestamp":1760587250000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging"],"prefix":"10.1053","volume":"56","author":[{"given":"Takahiro","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-1689","authenticated-orcid":false,"given":"Xinyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3175-952X","authenticated-orcid":false,"given":"Sophie C.","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7927-6226","authenticated-orcid":false,"given":"Daniel","family":"Gr\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fischereder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-6046","authenticated-orcid":false,"given":"Rudolf A.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1053\/j.semnuclmed.2025.09.008_bib0001","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.7150\/thno.102552","article-title":"Molecular imaging along the heart-kidney axis","volume":"14","author":"Klimek","year":"2024","journal-title":"Theranostics"},{"key":"10.1053\/j.semnuclmed.2025.09.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.124.24441","article-title":"Redefining AT1 receptor PET imaging: introducing the radiotracer [(18)F]DR29","author":"Chen","year":"2025","journal-title":"Hypertension"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.09.008_bib0003","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.7150\/thno.63205","article-title":"Molecular imaging-derived biomarker of cardiac nerve integrity - introducing high NET affinity PET probe (18)F-AF78","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1053\/j.semnuclmed.2025.09.008_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102055","article-title":"PET imaging of sodium-glucose cotransporters (SGLTs): unveiling metabolic dynamics in diabetes and oncology","volume":"90","author":"Klimek","year":"2024","journal-title":"Mol Metab"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.09.008_bib0006","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.118.037778","article-title":"Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG OUTCOME trial","volume":"139","author":"Fitchett","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.09.008_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tcm.2019.02.007","article-title":"Recent paradigm shifts in molecular cardiac imaging-establishing precision cardiology through novel (18)F-labeled PET radiotracers","volume":"30","author":"Werner","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.09.008_bib0008","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2967\/jnumed.116.172718","article-title":"Initial preclinical evaluation of 18F-fluorodeoxysorbitol PET as a novel functional renal imaging agent","volume":"57","author":"Wakabayashi","year":"2016","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.09.008_bib0009","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2967\/jnumed.117.203828","article-title":"Functional renal imaging with 2-deoxy-2-(18)F-fluorosorbitol PET in rat models of renal disorders","volume":"59","author":"Werner","year":"2018","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.09.008_bib0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/RLU.0000000000002494","article-title":"Novel functional renal PET imaging with 18F-FDS in Human subjects","volume":"44","author":"Werner","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.09.008_bib0011","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10557-017-6733-2","article-title":"The pharmacogenomic and metabolomic predictors of ACE inhibitor and angiotensin II receptor blocker effectiveness and safety","volume":"31","author":"Flaten","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0012","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/HYPERTENSIONAHA.107.102715","article-title":"Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis","volume":"51","author":"Xia","year":"2008","journal-title":"Hypertension"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.09.008_bib0013","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2967\/jnumed.115.170951","article-title":"Characterization of 18F-FPyKYNE-Losartan for imaging AT1 receptors","volume":"57","author":"Hachem","year":"2016","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.09.008_bib0014","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1021\/acsomega.8b01885","article-title":"(18)F-labeled PET imaging agent FV45 targeting the renin-angiotensin system","volume":"3","author":"Chen","year":"2018","journal-title":"ACS Omega"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.09.008_bib0015","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcmg.2019.01.042","article-title":"Nuclear imaging of the cardiac sympathetic nervous system: a disease-specific interpretation in heart failure","volume":"13","author":"Zelt","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"20","key":"10.1053\/j.semnuclmed.2025.09.008_bib0016","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.09.008_bib0017","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s12350-019-01859-w","article-title":"Prognostic usefulness of planar (123)I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: follow-up data from ADMIRE-HF","volume":"28","author":"Agostini","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.09.008_bib0018","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12471-021-01633-z","article-title":"Endovascular renal sympathetic denervation to improve heart failure with reduced ejection fraction: the IMPROVE-HF-I study","volume":"30","author":"Feyz","year":"2022","journal-title":"Neth Heart J"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.09.008_bib0019","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1007\/s12350-019-01598-y","article-title":"Renal sympathetic denervation in patients with vasospastic angina","volume":"27","author":"Feyz","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11906-013-0328-5","article-title":"Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options","volume":"15","author":"Vink","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0021","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12350-016-0760-4","article-title":"Significant correlation between renal (123)I-metaiodobenzylguanidine scintigraphy and muscle sympathetic nerve activity in patients with primary hypertension","volume":"24","author":"Takamura","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/mol.120.119495","article-title":"Characterization of meta-iodobenzylguanidine (mIBG) transport by polyspecific organic cation transporters: implication for mIBG therapy","volume":"98","author":"Lopez Quinones","year":"2020","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.09.008_bib0023","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers","volume":"23","author":"Henzlova","year":"2016","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0024","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12350-016-0764-0","article-title":"(123)I-mIBG scintigraphy: clinical tool for assessing renal sympathetic activity?","volume":"24","author":"George","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.09.008_bib0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40336-018-0289-4","article-title":"SPECT vs. PET in cardiac innervation imaging: clash of the titans","volume":"6","author":"Werner","year":"2018","journal-title":"Clin Transl Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020690","article-title":"Rationalizing the binding modes of PET radiotracers targeting the norepinephrine transporter","volume":"15","author":"Tutov","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1053\/j.semnuclmed.2025.09.008_bib0027","unstructured":"https:\/\/rctportal.mhlw.go.jp\/en\/detail?trial_id=jRCTs051250025, last assessed September 3, 2025."},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.09.008_bib0028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.117.028268","article-title":"Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease","volume":"137","author":"Wanner","year":"2018","journal-title":"Circulation"},{"issue":"15","key":"10.1053\/j.semnuclmed.2025.09.008_bib0029","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2025.09.008_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4635171","article-title":"In vivo functional assessment of sodium-glucose cotransporters (SGLTs) using [(18)F]Me4FDG PET in rats","volume":"2022","author":"Matsusaka","year":"2022","journal-title":"Mol Imaging."},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.09.008_bib0031","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13550-024-01098-2","article-title":"In vivo assessment of safety, biodistribution, and radiation dosimetry of the [(18)F]Me4FDG PET-radiotracer in adults","volume":"14","author":"Geist","year":"2024","journal-title":"EJNMMI Res"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.09.008_bib0032","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1007\/s00259-023-06256-7","article-title":"Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus","volume":"50","author":"Geist","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:14:29Z","timestamp":1773904469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299825001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0001299825001242"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.09.008","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}